SCHEMBL17040205

SCHEMBL17040205

O=C(O)c1cc(C(=O)O)c2cccccc1-2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
ALOX15 P16050 1/20 0.60
FOLH1 Q04609 2/20 0.57
CYP2C9 P11712 3/20 0.54
CYP2C8 P10632 1/20 0.54
ALOX12 P18054 2/20 0.52
CYP3A4 P08684 1/20 0.52
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TSHR P16473 1/20 0.50
ATIC P31939 1/20 0.50
HNF4A P41235 1/20 0.50
KDM4E B2RXH2 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
HMGB1 P09429 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA7 P43166 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31517184 0.90 ALDH1A1 (0.55) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
SCHEMBL31517180 0.90 ALDH1A1 (0.55) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
Pyromellitic Acid SCHEMBL28311393 0.89 ALDH1A1 (0.60) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
SCHEMBL18364471 0.89 FOLH1 (0.49) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
SCHEMBL36145 0.86 ALDH1A1 (0.72) ALDH1A1ALOX15FOLH1CYP2C9ALOX12
SCHEMBL30028907 0.86 ALDH1A1 (0.72) ALDH1A1ALOX15FOLH1CYP2C9ALOX12
SCHEMBL31517115 0.85 ACMSD (0.59) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
SCHEMBL28039539 0.85 ALDH1A1 (0.50) ALDH1A1ALOX15FOLH1CYP2C9CYP2C8
SCHEMBL30888405 0.84 ALDH1A1 (0.62) ALDH1A1ALOX15FOLH1CYP2C9ALOX12
SCHEMBL2944662 0.84 ALDH1A1 (0.62) ALDH1A1ALOX15FOLH1CYP2C9ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1886130-A Use of 2-thia-dibenzo [ e, h ] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders PLIVA ISTRAZIVACKI INST D O O (HR) 2006-12-27 CN claimed
EP-4304766-A1 MEMBRANE DEVICE Evove Ltd (GB) 2024-01-17 EP disclosed
EP-4304765-A1 SPACER FOR A SPIRAL WOUND MEMBRANE Evove Ltd (GB) 2024-01-17 EP disclosed
WO-2022189793-A1 MEMBRANE DEVICE EVOVE LTD (GB) 2022-09-15 WO disclosed
WO-2022189785-A1 SPACER FOR A SPIRAL WOUND MEMBRANE EVOVE LTD (GB) 2022-09-15 WO disclosed
CN-108424745-B Active energy ray-polymerizable resin composition, adhesive, coating agent, laminate, and use of laminate 东洋油墨SC控股株式会社 2021-06-15 CN disclosed
CN-107619409-B Join Azulene diimide derivative, preparation method and application 中国科学院上海有机化学研究所 2019-10-22 CN disclosed
US-10287304-B2 Acid, solvent, and thermal resistant metal-organic frameworks THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-05-14 US disclosed
CN-107619409-A Join Azulene diimide derivative, its preparation method and application 中国科学院上海有机化学研究所 2018-01-23 CN disclosed
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-01-12 US disclosed
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-01-12 US disclosed
WO-2015127033-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-08-27 WO disclosed
CN-1886130-A Use of 2-thia-dibenzo [ e, h ] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders PLIVA ISTRAZIVACKI INST D O O (HR) 2006-12-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287304-B2 Acid, solvent, and thermal resistant metal-organic frameworks HAO2, ASF1A, FTO ALDH1A1 639/4885ALOX15 634/4885FOLH1 1623/4885
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS HAO2, ASF1A, FTO ALDH1A1 639/4885ALOX15 634/4885FOLH1 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.